Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Title:
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Author:
Heuser, Michael Smith, B. Douglas Fiedler, Walter Sekeres, Mikkael A. Montesinos, Pau Leber, Brian Merchant, Akil Papayannidis, Cristina Pérez-Simón, José A. Hoang, Caroline J. O’Brien, Thomas Ma, Weidong Wendy Zeremski, Mirjana O’Connell, Ashleigh Chan, Geoffrey Cortes, Jorge E.